AccuSift provides high-performance Rifampicin competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Rifampicin is a broad-spectrum antibiotic belonging to the rifamycin family. It exhibits strong antibacterial activity against Mycobacterium tuberculosisand is also effective against Gram-positive and Gram-negative bacteria, as well as certain viruses. It is primarily used to treat tuberculosis, meningitis, and Staphylococcus aureusinfections, and can be applied topically for trachoma.On October 27, 2017, the World Health Organization's International Agency for Research on Cancer (IARC) categorized rifampicin as a Group 3 carcinogen in its preliminary list of carcinogens.Performance Characteristics:
•Sensitivity: ELISA IC50: 0.2 ppb
•Cross-Reactivity: Rifamycin B 2 ppb, Rifamycin S 2 ppb, Rifaximin 1 ppb, Rifapentine 1 ppb
•Source: Mouse Monoclonal Antibody
•Purity: ≥ 90%
•Recommended Pairing: (Coating) / (Labeling)
•Storage: Long-term storage at ≤ -20°C; short-term storage at 2-8°C. Shipped on ice packs.
WeChat
